Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Ophthalmic manifestations of dementing disorders

Douglas VP, Douglas KAA, Cestari DM.

Curr Opin Ophthalmol. 2021 Nov 1;32(6):515-520. doi: 10.1097/ICU.0000000000000807.

Single-cell Transcriptional Changes in Neurodegenerative Diseases

Ahmadi A, Gispert JD, Navarro A, Vilor-Tejedor N, Sadeghi I.

Neuroscience. 2021 Dec 15;479:192-205. doi: 10.1016/j.neuroscience.2021.10.025. Epub 2021 Nov 6.

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease

Adeyemi OS, Awakan OJ, Afolabi LB, Rotimi DE, Oluwayemi E, Otuechere CA, Ibraheem O, Elebiyo TC, Alejolowo O, Arowolo AT.

Oxid Med Cell Longev. 2021 Nov 10;2021:5522981. doi: 10.1155/2021/5522981. eCollection 2021.

Insight γ-Secretase: Structure, Function, and Role in Alzheimer's Disease

Mal S, Malik U, Pal D, Mishra A.

Curr Drug Targets. 2021;22(12):1376-1403. doi: 10.2174/1389450121999201230203709.

[Causes and Consequences of Genome Instability in Psychiatric and Neurodegenerative Diseases]

Iourov IY, Vorsanova SG, Kurinnaia OS, Zelenova MA, Vasin KS, Yurov YB.

Mol Biol (Mosk). 2021 Jan-Feb;55(1):42-53. doi: 10.31857/S0026898421010158.

Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease

Zhao X, Kumari D, Miller CJ, Kim GY, Hayward B, Vitalo AG, Pinto RM, Usdin K.

J Huntingtons Dis. 2021;10(1):149-163. doi: 10.3233/JHD-200423.

DNA Damage-Induced Neurodegeneration in Accelerated Ageing and Alzheimer's Disease

Wang H, Lautrup S, Caponio D, Zhang J, Fang EF.

Int J Mol Sci. 2021 Jun 23;22(13):6748. doi: 10.3390/ijms22136748.

Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials

Magham SV, Thaggikuppe Krishnamurthy P, Shaji N, Mani L, Balasubramanian S.

J Neurosci Res. 2021 Nov;99(11):2888-2905. doi: 10.1002/jnr.24933. Epub 2021 Sep 6.

Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease

Lane DJR, Metselaar B, Greenough M, Bush AI, Ayton SJ.

Essays Biochem. 2021 Dec 22;65(7):925-940. doi: 10.1042/EBC20210017.

The role of magnetic fields in neurodegenerative diseases

Riancho J, Sanchez de la Torre JR, Paz-Fajardo L, Limia C, Santurtun A, Cifra M, Kourtidis K, Fdez-Arroyabe P.

Int J Biometeorol. 2021 Jan;65(1):107-117. doi: 10.1007/s00484-020-01896-y. Epub 2020 Mar 20.

Electroencephalogram in dementia with Lewy bodies: a systematic review

Chatzikonstantinou S, McKenna J, Karantali E, Petridis F, Kazis D, Mavroudis I.

Aging Clin Exp Res. 2021 May;33(5):1197-1208. doi: 10.1007/s40520-020-01576-2. Epub 2020 May 7.

Multi-angle development of therapeutic methods for Alzheimer's disease

Hoshi M.

Br J Pharmacol. 2021 Feb;178(4):770-783. doi: 10.1111/bph.15174. Epub 2020 Jul 16.

Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field

Smedinga M, Darweesh SKL, Bloem BR, Post B, Richard E.

J Neurol. 2021 Feb;268(2):724-733. doi: 10.1007/s00415-020-10162-5. Epub 2020 Aug 18.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.

Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage

Farr AC, Xiong MP.

Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias